The Jinling Cohort

RecruitingOBSERVATIONAL
Enrollment

15,000

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

May 15, 2027

Study Completion Date

May 15, 2027

Conditions
CancerMulti Cancer Early ScreeningLiquid Biopsy
Interventions
OTHER

MERCURY test, health questionnaires and annual routine physical exams

Each participant will undergo peripheral blood collection for MERCURY test, health questionnaires and annual routine physical exams once a year for three consecutive years, then followed up two additional years.

Trial Locations (2)

210000

RECRUITING

Nanjing Jiangbei People's Hospital, Nanjing

RECRUITING

The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

Nanjing Shihejiyin Technology, Inc.

INDUSTRY